Welcome to our dedicated page for Ingredion news (Ticker: INGR), a resource for investors and traders seeking the latest updates and insights on Ingredion stock.
Ingredion Incorporated reports developments tied to its global ingredient solutions business for food, beverage, animal nutrition, brewing, industrial and pharmaceutical applications. Company news commonly covers quarterly and full-year earnings, operating income drivers, guidance, dividends and share repurchase activity, along with demand, volume and cost trends in its ingredient businesses.
Updates also address Ingredion's plant-based materials portfolio, including starches, sweeteners, texturizers, plant-based proteins and functional excipients. Other recurring themes include responsible sourcing and regenerative agriculture initiatives, distribution arrangements for Ingredion Pharma Solutions, board and executive governance changes, and restructuring or facility actions that affect manufacturing operations.
Ingredion (NYSE: INGR) reported second quarter 2026 net sales of $1.85 billion, up 1% year over year. Reported operating income fell 31% to $188 million, while adjusted operating income declined 5% to $258 million. Reported and adjusted diluted EPS were $1.78 and $2.82, versus $2.99 and $2.87 in 2025.
Texture & Healthful Solutions net sales rose 5% to $627 million and segment operating income increased 5% to $117 million. Food & Industrial Ingredients—LATAM operating income decreased 7% to $118 million, and Food & Industrial Ingredients—U.S./CAN operating income dropped 33% to $58 million, impacted by earlier production issues at the Argo plant.
Ingredion completed the sale of a majority stake in its Pakistan business and reported that shareholders of Tate & Lyle accepted its 595 pence all-cash offer, advancing the pending acquisition. The company reaffirmed 2026 guidance for reported EPS of $9.15–$9.75 and adjusted EPS of $10.30–$10.90, expects full-year net sales to be flat to up low single digits, cash from operations of $700–$800 million, and capital expenditures of $450–$490 million.
Ingredion (NYSE: INGR) confirmed that shareholders of Tate & Lyle have accepted its recommended 595 pence per share all-cash offer for the entire issued and to be issued share capital of Tate & Lyle, originally announced on June 8, 2026.
According to Ingredion, the transaction is expected to generate approximately $130 million in run-rate net cost synergies, fully realized by the end of 2030, and to be adjusted EPS accretive in the first year following completion. Regulatory review and clearance are ongoing, and the companies will continue to operate separately until closing, which is currently expected in the second half of 2027.
Ingredion (NYSE: INGR) will release its second quarter 2026 financial results for the period ended June 30, 2026, before the market opens on Tuesday, August 4, 2026. Jim Zallie, chairman, president and CEO, and Jason Payant, vice president and interim CFO, will host a conference call at 8 a.m. CT the same day.
The call and slide presentation will be webcast live on Ingredion's investor relations website, with a replay available later on the site. Participants are advised to log on about 10 minutes early.
Ingredion (NYSE: INGR) completed the sale of a 51% equity interest in its Pakistan business, Rafhan Maize, to a purchaser group led by Nishat Hotels and Properties for approximately $165 million.
Ingredion retains about 20% ownership. The Pakistan business generated unaudited 2025 net sales of ~$250 million. Management highlights reduced earnings volatility, capital for higher-growth investments, and continued access to Middle East and South Asia markets.
Ingredion (NYSE: INGR) appointed Kenneth Escoe to its board of directors, effective July 1. Escoe is executive vice president of Specialty Products at Illinois Tool Works and brings experience in capital-intensive businesses, global operations, food and beverage packaging, and M&A-driven growth.
Ingredion (NYSE: INGR) announced a recommended all-cash acquisition of Tate & Lyle, valuing the target at approximately £3.7B ($5.0B). Tate & Lyle shareholders will receive 595p per share, a ~59% premium, plus specified dividends. Ingredion targets $130M run-rate cost synergies by 2030, with about $175M one-time costs, expects the deal to be adjusted EPS accretive in the first year post-close, and sees completion in H2 2027, funded by cash, new debt and a committed bridge, at around 3.0x net debt/EBITDA at closing.
Ingredion (NYSE: INGR) announced the acquisition of Benicaros, a patented prebiotic fiber made from upcycled carrot pomace and clinically shown to support immune health.
Benicaros delivers benefits at very low dosage, is water-soluble, clean-label, and suitable for foods, beverages, and supplements. The asset deal includes all intellectual property, trademarks, human clinical trials, and manufacturing know-how.
Ingredion (NYSE: INGR) announced a strategic joint venture with Sanstar Limited, including a 9% equity investment in India’s leading corn-based specialty products manufacturer. The partnership targets high-growth pharma and food ingredient markets in India.
The companies will build a greenfield facility to produce specialty pharmaceutical and other high-value ingredient products, creating a vertically integrated, science-led platform serving food, beverage, pharmaceutical, home and beauty customers and supporting export opportunities from India.
Ingredion (NYSE: INGR) reported major progress in its 2025 Sustainability Report, achieving 96.3% sustainable sourcing of tier 1 priority crops, up from 25% five years ago. These crops include corn, tapioca, potato, stevia and pulses.
The company follows verified industry standards covering environmental and social thresholds across the crop lifecycle. Other 2025 highlights include diverting 95% of operational waste from landfills, reaching zero waste to landfill at 16 plants, launching a stand-alone Human Rights Policy, growing an upcycled ingredients portfolio to 50+ certified products, and starting an end-to-end sustainable innovation program.
Ingredion (NYSE: INGR) announced that its board declared a quarterly dividend of $0.82 per share on its common stock. The dividend is payable on July 21, 2026, to shareholders of record as of the close of business on July 1, 2026.